ClinicalTrials.Veeva

Menu

Physiological Effects of High-Flow Tracheal Oxygen Via An Modified Interface

C

Capital Medical University

Status

Completed

Conditions

Tracheostomy

Treatments

Procedure: The modified HFT

Study type

Observational

Funder types

Other

Identifiers

NCT03244761
KY-2017-CC-13

Details and patient eligibility

About

Tracheostomy is often performed in patients after or anticipated prolonged mechanical ventilation, who are usually required oxygen therapy after discontinuation of mechanical ventilation.

Full description

Tracheostomy is often performed in patients after or anticipated prolonged mechanical ventilation, who are usually required oxygen therapy after discontinuation of mechanical ventilation.The high-flow tracheal (HFT) oxygen therapy in tracheostomized patients has been shown that can improve oxygenation,but can not induce positive end-expiratory pressure and elevation of end-expiratory lung volume. A modified HFT system by increasing expiratory resistance might induce PEEP and consequently elevate EELV.

Enrollment

20 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The tracheostomized patient requiring the convenient oxygen therapy.

Exclusion criteria

  • Under 18 years;
  • history of esophageal, gastric or lung surgery;
  • The contraindication of using EIT (pacemaker, defibrillator, and implantable pumps).

Trial design

20 participants in 2 patient groups

The standard HFT
Description:
The high-flow oxygen was delivered via tracheostomy using a standard HFT.
The modified HFT
Description:
The high-flow oxygen was delivered via tracheostomy using a modified HFT.
Treatment:
Procedure: The modified HFT

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems